Analyst Ratings for Arcturus Therapeutics (ARCT)
ARCT Rating Summary
ARCT Price Target Summary
- Highest: $68.00 (Laidlaw)
- Lowest: $8.00 (Citi)
- Average: $23.56
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.56 (+289.3%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 65%
Avg. $ Target:
$23.56 (+289.3%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/2/2026 | Freedom Broker | N/A | New Coverage | Buy (N/A) |
27.00 (N/A) |
6.89 (6.05) |
-12.19% | Details |
| 3/18/2026 | B.Riley | Mayank Mamtani | New Coverage | Buy (N/A) |
22.00 (N/A) |
6.63 (6.05) |
-8.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
